Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Calin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncology Reports|May 25, 2011
Oncogenes and tumor-suppressor genes - 2 different looks of the same geneG Calin
Oncology Reports|May 21, 2011
Can the loss of negative regulation theory be compatible with the development of hematological malignancies - (review)G Calin, D Stefanescu
Oncology Reports|May 25, 2011
A complex translocation t(1-12-11) in a patient with hodgkins-diseaseD Stefanescu, D Colita, G Calin
European Journal of Human Genetics : EJHG|January 1, 1997
Genetic services in RomaniaC Maximilian, D Stefanescu, G Calin
Medical Hypotheses|December 23, 1999
The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanationsG Calin, M Ivan, D Stefanescu
Cancer Research|September 10, 1998
The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumorsG Calin, V Herlea, G Barbanti-Brodano, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 1998
Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administrationC Mircioiu, A Perju, A Neagu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 1998
Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administrationC Mircioiu, A Perju, E Griu, et al.
BMC Genetics|September 5, 2001
Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotypeG Calin, G N Ranzani, D Amadori, et al.
Cancer Research|April 18, 2001
Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemiaH Mabuchi, H Fujii, G Calin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncology Reports|May 25, 2011
Oncogenes and tumor-suppressor genes - 2 different looks of the same geneG Calin
Oncology Reports|May 21, 2011
Can the loss of negative regulation theory be compatible with the development of hematological malignancies - (review)G Calin, D Stefanescu
Oncology Reports|May 25, 2011
A complex translocation t(1-12-11) in a patient with hodgkins-diseaseD Stefanescu, D Colita, G Calin
European Journal of Human Genetics : EJHG|January 1, 1997
Genetic services in RomaniaC Maximilian, D Stefanescu, G Calin
Medical Hypotheses|December 23, 1999
The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanationsG Calin, M Ivan, D Stefanescu
Cancer Research|September 10, 1998
The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumorsG Calin, V Herlea, G Barbanti-Brodano, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 1998
Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administrationC Mircioiu, A Perju, A Neagu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 1998
Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administrationC Mircioiu, A Perju, E Griu, et al.
BMC Genetics|September 5, 2001
Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotypeG Calin, G N Ranzani, D Amadori, et al.
Cancer Research|April 18, 2001
Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemiaH Mabuchi, H Fujii, G Calin, et al.
Pageof 2